FDA Covid-19 Update: Serological Test Validation and Education Efforts
The question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation.
Read MorePosted by | Apr 22, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation.
Read MorePosted by | Apr 14, 2020 | Coagulation Testing, Hematology & Serology, Hematology Instrumentation, POC Instruments, POC Rapid Assays, POC Reagents & Test Kits, Point-of-Care |
The Allegro and its StatStrip-A companion meter now provide 18 tests to help physicians make therapeutic decisions and adjustments at the point of care.
Read MorePosted by | Apr 10, 2020 | Blood Banking, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases |
Based on recently completed studies and epidemiologic data, FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply.
Read MorePosted by | Mar 31, 2020 | Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The Diazyme DZ-Lite SARS-CoV-2 IgG and SARS-CoV-2 IgM CLIA test kits are run on the fully automated Diazyme DZ-Lite 3000 Plus chemiluminescence analyzer.
Read MorePosted by | Mar 30, 2020 | Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The DPP Covid-19 IgM/IgG system is a single-use rapid point-of-care test for the detection and differentiation of IgM and IgG antibodies to covid-19 in whole blood.
Read More